Sign in

European Headache Federation

@ehfofficial.bsky.social
51 followers 38 following 155 posts

Improving awareness of headache disorders and their impact across Europe. Official journal: Journal of Headache and Pain

PostsRepliesMedia
European Headache Federation @ehfofficial.bsky.social · 17/09/2026
Comparative efficacy and safety of prophylactic agents for #migraine in children and adolescents. Riboflavin, topiramate-vitaminD, and levetiracetam showed the most consistent frequency signal, but CINeMA found no comparison reached high or moderate certainty. Open access: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 15/09/2026
Combined Idiopathic Intracranial Hypertension score, an integrated severity and treatment-oriented tool for idiopathic intracranial hypertension: a retrospective cohort study. Open access: doi.org/10.1186/s101... #neurology #medicine #intracranialhypertension #headache #ophthalmology
000
European Headache Federation @ehfofficial.bsky.social · 08/09/2026
Can AI help distinguish primary from secondary headache? An explainable machine-learning model achieved high diagnostic performance (AUC 0.905), with associated symptoms and triggers contributing more to classification than pain intensity. ➡️ doi.org/10.1177/0333...
010
European Headache Federation @ehfofficial.bsky.social · 08/09/2026
Substance P and PACAP activate dural mast cells through MRGPRX2, highlighting a potential new pathway in headache mechanisms. ➡️https://doi.org/10.1177/03331024261480167
000
European Headache Federation @ehfofficial.bsky.social · 03/09/2026
A recent longitudinal study found a significantly greater burden of autonomic symptoms in patients with acute post-traumatic headache after mild traumatic brain injury. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 31/08/2026
The results from the MI-DEAR study highlight the often-overlooked burden of migraine on caregivers: lower reciprocity within the patient–caregiver relationship, greater depressive symptoms, and higher migraine burden were associated with increased caregiver distress. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 31/08/2026
A recent preclinical study shows that botulinum toxin type A may attenuate trigeminal neuralgia-like pain by reducing CGRP release and modulating NaV1.7-related signaling, providing new insights into its analgesic mechanisms. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 03/08/2026
A new study has been published exploring the role of CGRP in idiopathic intracranial hypertension (IIH)-associated headache. In this study, the authors measured CGRP in tear fluid of IIH patients before and after therapeutic lumbar puncture. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 29/07/2026
People with chronic headache often have neck problems. A new study compared cervical musculoskeletal function in chronic migraine, chronic tension-type headache, and chronic cluster headache. Neck movement impairments were common across all chronic headache disorders. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 19/07/2026
Does episodic cluster headache involve persistent alterations in brain connectivity even between individual attacks? Read more this new study ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 18/07/2026
A recent study examined age-related changes in CGRP release from the trigeminovascular system using a mouse model of accelerated neuronal and vascular aging. 🧠🐁 ➡️https://doi.org/10.1186/s10194-026-02441-9
000
European Headache Federation @ehfofficial.bsky.social · 18/07/2026
Does cerebrovascular reactivity change during a migraine attack? This recent fMRI study found no overall differences between the ictal and interictal phases. However, side-specific changes were observed according to headache laterality. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 17/07/2026
What happens to hypothalamic metabolism in chronic cluster headache? 🧠 Using ultra-high-field 7-T spectroscopy, this first-of-its-kind study found significantly reduced hypothalamic glutamate in patients with chronic cluster headache. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 17/07/2026
How are sleep quality and chronotype associated with primary headache disorders? Poor sleep quality and an evening chronotype are prominent features of primary headache disorders, especially migraine. Read the full article: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 16/07/2026
Is migraine better understood as a spectrum rather than as separate “episodic” and “chronic” disorders? doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 11/06/2026
Migraine and Meniere’s disease show high comorbidity and shared symptoms. A recent study provides new insight of a shared genetic and cellular basis between the two conditions. Using GWAS and single-cell analyses, researchers identified overlapping risk genes. Read: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 08/06/2026
Neuropathic pain remains notoriously difficult to treat, the mechanisms driving it are still unclear. A recent preclinical study highlight a compelling link between metabolism and pain and suggest the FGF4/HIF-1α axis as a potential target for future therapies. Read: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 29/05/2026
What exactly should be considered a “migraine day”? A new international study proposes a consensus-based definition, developed through expert agreement, to help standardize migraine research and clinical practice. ➡️ doi.org/10.1186/s101... #Migraine #HeadacheResearch #Neurology
000
European Headache Federation @ehfofficial.bsky.social · 29/05/2026
This new study examined whether network-level BOLD-CSF coupling alterations were differentially distributed across migraine subtypes and whether such alterations were associated with a deep learning estimation of the brain age gap. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 28/05/2026
Data from RCT (eptinezumab vs placebo) showed more favorable improvements in eptinezumab in multiple patient-reported outcomes (PROs) capturing headache-related life impact. ➡️ doi.org/10.1177/0333...
000
European Headache Federation @ehfofficial.bsky.social · 27/05/2026
A pilot study suggests that pharmacist-led migraine consultations may enhance patient education and self-management, highlighting a potential role for community pharmacies in migraine care as a complement to existing headache care pathways. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 26/05/2026
Structural brain MRI changes following 6 months of preventive treatment with erenumab or onabotulinumtoxinA in migraine. 📖 Read the article: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 11/05/2026
Breaking the medication overuse headache cycle: from nociplastic pain mechanisms to patient-centered interventions. Reframing MOH within a nociplastic pain framework supports a shift from rigid detoxification models toward personalized, mechanism-based, and multidisciplinary care. rdcu.be/fh6gp
000
European Headache Federation @ehfofficial.bsky.social · 27/04/2026
Understanding how pain and emotional symptoms are linked remains a major challenge in headache research. A recent preclinical study sheds light on a specific cortico-thalamic circuit that may play a key role in this connection. Read more: lnkd.in/e6qvnr-R
000
European Headache Federation @ehfofficial.bsky.social · 24/04/2026
📢Call for Papers – The Journal of Headache and Pain 📢 Exciting opportunities to contribute to upcoming thematic collections in The Journal of Headache and Pain: Headache & Sustainable Development Goals, Focus India and Chronobiology of Headaches. See more: link.springer.com/journal/1019...
000
European Headache Federation @ehfofficial.bsky.social · 20/04/2026
Migraine and fertility treatments: what’s the link? This systematic review explores how assisted reproductive technologies and hormonal interventions may influence headache disorders. 📖 doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 19/04/2026
Research published in The Journal of Headache and Pain explores the role of biochemical markers—such as CGRP, cytokines, and mitochondrial factors—in children with migraine. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 19/04/2026
A large systematic review shows that migraine may be associated with an increased risk of retinal vascular events and macular disorders. 🧠 👁️‍🗨️ 📖 Read the full article: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 18/04/2026
A recent systematic review in Cephalalgia examines current clinical guidelines for managing migraine in children and adolescents. 🔍 The study underscores the need for more pediatric-focused research and updated, harmonized guidelines to improve care. 📖 Read more: doi.org/10.1177/0333...
000
European Headache Federation @ehfofficial.bsky.social · 17/04/2026
A recent study in The Journal of Headache and Pain explores how epigenetic changes may play a role in migraine and medication overuse headache, and how these patterns evolve after medication withdrawal. 📖 Full article: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 02/04/2026
Forecasting #migraine with time-series machine learning from mobile health data. The most important features were #headache intensity, duration of the headache, and heart rate scores. Open access: link.springer.com/article/10.1...
000
European Headache Federation @ehfofficial.bsky.social · 30/03/2026
Shift work #migraine disorder (SWMD): evidence, mechanisms, and implications for diagnosis, prevention, and management. Open access: link.springer.com/article/10.1...
000
European Headache Federation @ehfofficial.bsky.social · 23/03/2026
A prospective study examined fluid biomarkers in idiopathic intracranial hypertension to better understand pathophysiology. The authors measured serum and CSF proteins and explored their relationship with intracranial pressure and visual outcomes. Read the study: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 19/03/2026
A new neuroimaging study examined differences between migraine with depressive symptoms and migraine without. Brain dynamics distinguished the two groups, highlighting the potential for dynamic imaging biomarkers to identify migraine subtypes and guide treatment. Read: doi.org/10.1186/s101...
001
European Headache Federation @ehfofficial.bsky.social · 18/03/2026
A recent cross-sectional study of over 1,000 students from China highlights the high burden of headache disorders in children and adolescents and their links to lifestyle factors. Migraine and tension-type headache were common, yet only 8% had sought medical care. Read: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 16/03/2026
A new neuroimaging study explored the biology of medication-overuse headache in chronic migraine. The authors found reduced iron in the brains of chronic migraine patients with medication overuse headache. Lower iron was also associated with higher relapse rates. Read online: doi.org/10.1186/s101...
011
European Headache Federation @ehfofficial.bsky.social · 11/03/2026
A new paper published in Journal of Headache and Pain dissected the genetic relationship between temporomandibular disorders (TMD) and anxiety. TMD genetic risk includes both anxiety-related (~20%) and anxiety-independent components, with distinct biological pathways. doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 09/03/2026
🧠 Fractal dimension analysis of cortical MRI morphology can differentiate individuals with episodic migraine from healthy controls, suggesting that subtle alterations in cortical structural complexity may serve as potential imaging biomarkers of migraine. ➡️ doi:10.1177/03331024251414616
010
European Headache Federation @ehfofficial.bsky.social · 09/03/2026
A new review in The Journal of Headache and Pain explores the premonitory phase of primary headaches, highlighting shared and distinct mechanisms between migraine and cluster headache. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 09/03/2026
A recent study shows that Nr4a1 (nuclear receptor subfamily 4 group A member 1) modulates microglial overactivation and neuroinflammation in a rat model of trigeminal neuralgia. ➡️ doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 01/03/2026
🚨 Can blocking oxytocin receptors trigger a migraine attack? New research shows that acute oxytocin antagonism doesn't provoke attacks, suggesting a more complex modulatory role for this hormone. 🧠✨ doi.org/10.1186/s101...
100
European Headache Federation @ehfofficial.bsky.social · 27/02/2026
70 enthusiastic young doctors took part in the new School of Headache Essentials (SHE) – the first meeting on 20 February 2026 in Vilnius, Lithuania, was a great success! 🎉 Applications to host an SHE meeting will be accepted from 6 March. ➡️ www.ehf-headache.org/.../school-o....
010
European Headache Federation @ehfofficial.bsky.social · 13/02/2026
Hypothalamic and sex-related #hormones in #migraine. This review highlights the interplay between sex/reproductive hormones and hypothalamic hormones and their receptors in migraine-related neural structures. Open access: link.springer.com/article/10.1... #medicine #neurology #headache
Fig 1. Sagittal cryo-sections of the rat brain (schematic reworked from
[38]). The coloured dots on the sections represent the
immunohistochemical mapping of hormones and their receptors in the
volume spanning 0.5 to 1.5 mm from the midline of the brain. Our
group has earlier examined the distribution of hormones and their
receptors [38-40]. The present figure shows the migraine related
regions, CGRP, oxytocin, oestrogen, AVP and related receptors. OT:
Oxytocin, OTR: Oxytocin receptor, ERα: Estrogen receptor alpha, AVP:
Vasopressin, V1bR: Vasopressin receptor 1b.
000
European Headache Federation @ehfofficial.bsky.social · 11/02/2026
Interictal burden, not ictal burden, drives work productivity impairment in #headache disorders: insights from a Japanese cross-sectional study. Open access: link.springer.com/article/10.1... #neurology #migraine #medicine #burden
122
European Headache Federation @ehfofficial.bsky.social · 05/02/2026
Growing evidence shows that sleep disruption is a feature of primary headache disorders. A new systematic review found reduced sleep efficiency, increased night-time awakenings, and altered arousal patterns in migraine, with emerging similarities in cluster headache. Read: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 04/02/2026
New real-world data show effectiveness of eptinezumab in difficult-to-treat migraine patients. In a multi-centre study, ~70% of patients achieved a ≥50% reduction in migraine days within 6 months, with major improvements in disability and quality of life. Read more: doi.org/10.1186/s101...
000
European Headache Federation @ehfofficial.bsky.social · 02/02/2026
New preclinical evidence strengthens the link between CGRP and migraine-associated photophobia. CGRP induced light avoidance and headache-like pain in rats, closely mirroring human migraine provocation studies, offering strong translational relevance for studying migraine. doi.org/10.1186/s101...
021
European Headache Federation @ehfofficial.bsky.social · 30/01/2026
In a collaboration with Headache, Cephalalgia has published a series of 2025 highlights reflecting on a year of milestones across migraine and headache research. These highlights cutting-edge work in headache medicine. Read from the collection here: journals.sagepub.com/doi/full/10....
000
European Headache Federation @ehfofficial.bsky.social · 28/01/2026
This latest study reports the real-world data on medication-overuse headache from Egypt. A preventable cause of chronic headache with major impact on patients’ lives, especially in low- and middle-income settings: Read more: lnkd.in/eVWzaWja #Migraine #JournalOfHeadacheAndPain #MedicationOveruse
000
European Headache Federation @ehfofficial.bsky.social · 26/01/2026
A recent study introduces the “four dimensions (4D) migraine scale,” a composite tool that integrates key clinical and patient-centered features to better quantify migraine severity and treatment response. journals.sagepub.com/doi/10.1177/...
000